Sign in to continue:

Wednesday, March 4th, 2026

Credo Technology Group Holding Ltd 10-Q Report January 2026: Financial Highlights, Balance Sheet, and Forward-Looking Statements

Credo Technology Group Holding Ltd: Key Highlights from Q3 FY2026 (Form 10-Q)

Executive Summary

Credo Technology Group Holding Ltd has released its Quarterly Report on Form 10-Q for the period ended January 31, 2026. The report contains several important developments, financial results, and capital changes that shareholders and potential investors should note. This update includes forward-looking statements, recent capital raising activities, strong earnings results, and significant share issuance that could influence the company’s share price.

Key Financial Results

  • Net Income: The company reported a net income of \$15.6 million for the third quarter ended January 31, 2026. This result reflects continued profitability and operational improvement.
  • Earnings Per Share: Basic earnings per share for the quarter were \$0.09, with diluted earnings per share also at \$0.09. For the nine months ended January 31, 2026, basic EPS was \$1.72 and diluted EPS was \$1.62, indicating robust earnings momentum.
  • Revenue and Cash Flow: The company’s condensed consolidated financials show healthy cash positions and ongoing capital investment, with substantial amounts in short-term investments and cash equivalents.
  • Shareholder Equity: Total shareholders’ equity increased to \$1.85 billion as of January 31, 2026, up from \$1.29 billion at the previous reporting period, reflecting strong capital inflows and retained earnings.

Significant Capital Activities

  • At-The-Market Offerings: During the reporting period, Credo Technology issued 2,147,000 ordinary shares under its At-The-Market Offering program, netting a substantial capital inflow. The value of shares issued in this program was \$353.6 million in the third quarter, and \$353.6 million year-to-date.
  • Employee Stock Plans: The company continued to issue shares under equity incentive plans and employee stock purchase plans, resulting in 1,774,000 shares issued during the period, raising over \$4.6 million.
  • Customer Warrant Exercise: The company also issued ordinary shares upon the exercise of a customer warrant, further expanding its shareholder base.
  • Share-Based Compensation: Credo recognized \$52.2 million in share-based compensation expenses for the nine months ended January 31, 2026, reflecting ongoing efforts to incentivize and retain key personnel.

Other Financial and Operational Highlights

  • Short-Term Investments: At the end of the quarter, short-term investments stood at \$81 million, with a year-to-date total of \$195 million, indicating prudent liquidity management.
  • Weighted Average Shares Outstanding: The weighted average number of shares outstanding (basic) for the quarter was 166.6 million, and 186.6 million diluted, reflecting the impact of new share issuances.
  • Forward-Looking Statements: Management reiterated that the report includes forward-looking statements, including expectations regarding growth, capital requirements, and market trends. Investors are cautioned that actual results may differ due to various risks, including market competition, supply chain dependencies, and the need for additional financing.

Potential Price-Sensitive Information

  • The large capital raise via At-The-Market Offerings and significant increase in shareholders’ equity could signal to the market that Credo is strengthening its balance sheet, possibly preparing for strategic investments, M&A activity, or other growth initiatives.
  • The increase in share count through equity plans and warrant exercises may dilute existing shareholders but also demonstrates the company’s ability to attract capital and incentivize talent.
  • The company’s continued profitability and strong earnings per share outperformance are positive signals that may support the share price.

Share Count and Ownership

  • Ordinary Shares Outstanding: As of February 23, 2026, the company had 184,449,940 ordinary shares outstanding, up from 164,305,000 at the start of the fiscal year, representing notable share issuance activity.

Conclusion

Credo Technology Group Holding Ltd’s Q3 FY2026 report reveals a company in a strong financial position, actively raising capital, investing in growth, and delivering consistent profitability. The significant rise in shareholders’ equity and strategic use of equity offerings and employee incentives are key developments that could influence investor sentiment and share price performance. Shareholders should monitor future disclosures for additional information on how raised funds will be deployed and any potential dilution from further share issuances.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. The content is based on publicly available company filings and may include forward-looking statements subject to risks and uncertainties. Investors should perform their own due diligence or consult with a financial advisor before making investment decisions.

View Credo Technology Group Holding Ltd Historical chart here



Equity Residential to Join Citi 2026 Global Property CEO Conference and Releases Updated Investor Presentation

Equity Residential Investor News Update – February 27, 2026 Equity Residential Announces Participation in Citi 2026 Global Property CEO Conference and Provides Operating Update Chicago, IL – February 27, 2026: Equity Residential (NYSE: EQR),...

Westamerica Bancorporation 2025 Annual Report: Financials, Business Overview, and Regulatory Disclosures (Form 10-K)

Westamerica Bancorporation 2025 Annual Report: Detailed Investor Analysis Westamerica Bancorporation 2025 Annual Report: Key Highlights and Investor Insights Overview Westamerica Bancorporation, a leading bank holding company serving Northern and Central California, has released its...

Rigel Pharmaceuticals Reports Record 2025 Financial Results, Advances Clinical Programs, and Issues Positive 2026 Outlook

Rigel Pharmaceuticals Reports Record 2025 Results, Issues Bullish 2026 Outlook Rigel Pharmaceuticals Reports Record 2025 Financial Results and Bullish Outlook for 2026 Key Highlights for Investors Record 2025 Performance: Rigel Pharmaceuticals, Inc. reported record-breaking...

   Ad